Serving hundreds of leading biopharmaceutical companies globally:

Generated: October 19, 2018

DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-seven approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Teva Parenteral

US Patents:	0
Tradenames:	39
Ingredients:	37
NDAs:	47
Patent Litigation for Teva Parenteral:	See patent lawsuits for Teva Parenteral

Drugs and US Patents for Teva Parenteral

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-004	Dec 21, 1987		DISCN	Yes	No		➤ Sign Up				➤ Sign Up
Teva Parenteral	ERYTHROMYCIN LACTOBIONATE	erythromycin lactobionate	INJECTABLE;INJECTION	063253-001	Jul 30, 1993		DISCN	No	No		➤ Sign Up				➤ Sign Up
Teva Parenteral	CLINDAMYCIN PHOSPHATE	clindamycin phosphate	INJECTABLE;INJECTION	063282-001	May 29, 1992		DISCN	No	No		➤ Sign Up				➤ Sign Up
Teva Parenteral	DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	081126-001	Aug 31, 1990		DISCN	No	No		➤ Sign Up				➤ Sign Up
Teva Parenteral	ACYCLOVIR SODIUM	acyclovir sodium	INJECTABLE;INJECTION	074969-001	Aug 26, 1997		DISCN	No	No		➤ Sign Up				➤ Sign Up
Teva Parenteral	NEOSAR	cyclophosphamide	INJECTABLE;INJECTION	040015-004	Apr 29, 1993		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Teva Parenteral

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-001	Approved Prior to Jan 1, 1982	3,444,294	➤ Sign Up
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-002	Approved Prior to Jan 1, 1982	3,444,294	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office

Express Scripts

Julphar

AstraZeneca

Medtronic

Cantor Fitzgerald

QuintilesIMS

US Army

Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.